Menu
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

The Use of p16 FISH and BAP1 Immunohistochemistry in the Diagnostic Evaluation of Atypical Mesothelial Proliferations

CE Credits and Certificates of Attendance are no longer available for webinars more than 12 months old.

Overview

Mesothelial cell proliferations that are not unequivocally malignant are termed atypical mesothelial proliferations or atypical mesothelial hyperplasia. Frequently, pathologists are challenged with regards to classifying such mesothelial proliferations as representing a malignancy (i.e. mesothelioma) or benign reactive hyperplasia. This presentation will focus on the combined use of p16INK4a FISH and BAP1 immunohistochemistry as a diagnostic tool for the evaluation of such atypical mesothelial proliferations. A short overview of the diagnostic work-up of mesothelioma versus benign reactive mesothelial proliferations will be presented as well. Lastly, the impact on patient care for BAP1 and P16 FISH testing in this setting will be discussed.

Learning Objectives:

  1. Review of atypical mesothelial proliferations versus mesothelioma from a pathologist point of view.
  2. Diagnostic use of BAP1 IHC and p16 FISH will be discussed.
  3. Immunohistochemical and molecular testing for diagnosis of mesothelioma will be reviewed.
  4. Criteria for diagnosis of mesothelioma will also be reviewed and discussed.

Get Knowledge Pathway updates delivered directly to your inbox.

Want us to feature your writing?

We are looking for more great writers to feature here. Send us a submission and we'll be in touch!

Send your Writing!

Like what you see?

Get more Knowledge Pathway content like this delivered directly to your inbox. Unsubscribe at any time.